TY - JOUR T1 - Evaluation of pharmaceutical industry-led access programmes: a standardised framework JF - BMJ Global Health JO - BMJ Global Health DO - 10.1136/bmjgh-2019-001659 VL - 4 IS - 4 SP - e001659 AU - Peter C Rockers AU - Richard O Laing AU - Nancy Scott AU - Paul Ashigbie AU - Erin H Lucca AU - Chukwuemeka Anthony Umeh AU - Veronika J Wirtz Y1 - 2019/08/01 UR - http://gh.bmj.com/content/4/4/e001659.abstract N2 - Pharmaceutical industry-led access programmes are increasing in number and scope worldwide. We present a new standardised framework for evaluation of these programmes that includes three components: a taxonomy of 11 access programme strategies; a series of logic models, one for each strategy and a set of measurement indicators. The logic models describe pathways of potential programme impact. Concepts relevant across a broad range of strategies were prioritised for inclusion in logic models to ensure consistency and to facilitate synthesis and learning across programmes. Each concept has at least one corresponding measurement indicator with metadata that includes the definition, details on how it should be measured and recommended data sources. The framework establishes a shared language for the collection and reporting of meaningful industry-led access programme information. Broad adoption by programme developers and implementing partners in the for-profit sector and beyond could facilitate shared learning on effective strategies and best practices. ER -